Skip to main content
Jeffery Klco, MD, Pathology, Memphis, TN

Jeffery M Klco MD

Hematopathology, Anatomic Pathology, Clinical Pathology


Member and Director, Division of Hematopathology and Molecular Pathology

Join to View Full Profile
  • 262 Danny Thomas PlMemphis, TN 38105

  • Phone+1 901-595-6807

Dr. Klco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2007 - 2011
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematopathology, 2009 - 2010
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2007

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2014 - 2026
  • CA State Medical License
    CA State Medical License 2019 - 2025
  • MO State Medical License
    MO State Medical License 2011 - 2015
  • Pathology - Anatomic
    American Board of Pathology Pathology - Anatomic
  • Hematopathology
    American Board of Pathology Hematopathology

Awards, Honors, & Recognition

  • Member ASCI

Publications & Presentations

PubMed

Abstracts/Posters

  • Venetoclax in Combination with High-Dose Chemotherapy Is Active and Well-Tolerated in Children with Relapsed or Refractory Acute Myeloid LeukemiaClinically Relevant Ab...
    Jeffery M. Klco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome
    Jeffery M. Klco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses
    Jeffery M. Klco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Molecular Mechanisms of Bone Marrow Failure 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Targeting Oncogenic Fusions to Combat Pediatric Cancer Cells
    Targeting Oncogenic Fusions to Combat Pediatric Cancer CellsApril 7th, 2023
  • St. Jude Tool Targets Cancer-Causing Fusions’ Weak Spot
    St. Jude Tool Targets Cancer-Causing Fusions’ Weak SpotApril 5th, 2023
  • Newly Characterized Mutation May Define Novel Pediatric AML Subtype
    Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
  • Join now to see all

Grant Support

  • UBTF Tandem Duplications in Pediatric Acute Myeloid LeukemiaST. JUDE CHILDREN'S RESEARCH HOSPITAL2023–2028
  • Cross-species development and credentialing of pediatric AML modelsWASHINGTON UNIVERSITY2023–2028
  • UBTF Tandem Duplications in Pediatric Acute Myeloid LeukemiaST. JUDE CHILDREN'S RESEARCH HOSPITAL2023–2028
  • Cross-species development and credentialing of pediatric AML modelsWASHINGTON UNIVERSITY2023–2028
  • Cross-species development and credentialing of pediatric AML modelsWASHINGTON UNIVERSITY2023–2028
  • Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasiaST. JUDE CHILDREN'S RESEARCH HOSPITAL2019–2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: